1696 — Sisram Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSuper Stock

Annual income statement for Sisram Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	162	294	354	359	349
Cost of Revenue
Gross Profit	90.3	167	202	220	217
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	144	250	308	319	314
Operating Profit	17.7	44	46.7	40	35
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	16.7	41.7	44.2	37.1	32.5
Provision for Income Taxes
Net Income After Taxes	14.7	32.5	40.1	32.9	28.8
Minority Interest
Net Income Before Extraordinary Items
Net Income	13.3	31.2	40.2	31.5	25.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	13.3	31.2	40.2	31.5	25.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.029	0.069	0.086	0.067	0.046
Dividends per Share